Private Blood Bank Raided Running Without Licence In Gudivada

Vijayawada : The Drugs Control Administration (DCA) authorities swung into action and raided a private blood bank at Gudivada for operating in violation of norms and without a proper licence.

According to Gudivada drug inspector Dr J. Balu, MSR Blood Bank was resorting to storage, cross-matching and selling of blood despite its licence was cancelled.

Based on a complaint made in January, the blood bank was inspected and 12 blood bags of blood, three empty blood bags, blood storage refrigerators, equipment like Elisa washer and reader and some documents were seized.

Balu said that the blood bank was operated through a lab technician identified as Amarnath under the supervision of a Vijayawada-based doctor identified as Gopi and added that the quantum of seizure was about Rs. 7-8 lakh.

The drugs inspector said that as provision 18 (c ) of the Drugs and Cosmetics Act, 1940 was flouted, they booked a case and produced the culprits before the concerned court.

  • Related Posts

    • Pharma
    • February 17, 2025
    • 88 views
    GSK Pharma shares gain 20% following strong Q3FY25 results

    GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals Ltd…

    • Pharma
    • February 17, 2025
    • 76 views
    Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

    Shares of Glenmark Pharmaceuticals Ltd rose 4% on February 17 after the firm gave a strong guidance for FY26 and it returned to black in the December quarter. The drugmaker…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Wow! What a Change of Heart in Practitioners of Allopathy!

    Wow! What a Change of Heart in Practitioners of Allopathy!

    GSK Pharma shares gain 20% following strong Q3FY25 results

    GSK Pharma shares gain 20% following strong Q3FY25 results

    Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

    Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

    US Tariffs on pharma: What are the potential impact on Indian drugmakers

    US Tariffs on pharma: What are the potential impact on Indian drugmakers

    Twin Health bats a1000 before enters Digital Health NY 100

    Twin Health bats a1000 before enters Digital Health NY 100

    US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

    US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%